vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and WW INTERNATIONAL, INC. (WW). Click either name above to swap in a different company.

WW INTERNATIONAL, INC. is the larger business by last-quarter revenue ($184.3M vs $108.2M, roughly 1.7× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs -30.5%, a 76.4% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs -4.5%). ANAPTYSBIO, INC produced more free cash flow last quarter ($98.0M vs $8.4M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs -7.4%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

WW International, Inc., formerly Weight Watchers International, Inc., is a global company headquartered in the U.S. that offers weight loss and maintenance, fitness, and mindset services such as the Weight Watchers comprehensive diet program. Founded in 1963 by Queens, New York City homemaker Jean Nidetch, WW's program has three options as of 2019: online via its mobile app and website, coaching online or by phone, or in-person meetings.

ANAB vs WW — Head-to-Head

Bigger by revenue
WW
WW
1.7× larger
WW
$184.3M
$108.2M
ANAB
Growing faster (revenue YoY)
ANAB
ANAB
+155.6% gap
ANAB
151.1%
-4.5%
WW
Higher net margin
ANAB
ANAB
76.4% more per $
ANAB
45.8%
-30.5%
WW
More free cash flow
ANAB
ANAB
$89.6M more FCF
ANAB
$98.0M
$8.4M
WW
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
-7.4%
WW

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ANAB
ANAB
WW
WW
Revenue
$108.2M
$184.3M
Net Profit
$49.6M
$-56.3M
Gross Margin
72.2%
Operating Margin
61.8%
5.8%
Net Margin
45.8%
-30.5%
Revenue YoY
151.1%
-4.5%
Net Profit YoY
327.8%
-21.8%
EPS (diluted)
$1.64
$-5.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
WW
WW
Q4 25
$108.2M
Q3 25
$76.3M
$184.3M
Q2 25
$22.3M
Q1 25
$27.8M
$186.6M
Q4 24
$43.1M
$184.4M
Q3 24
$30.0M
$192.9M
Q2 24
$11.0M
$202.1M
Q1 24
$7.2M
$206.5M
Net Profit
ANAB
ANAB
WW
WW
Q4 25
$49.6M
Q3 25
$15.1M
$-56.3M
Q2 25
$-38.6M
Q1 25
$-39.3M
$-72.6M
Q4 24
$-21.8M
$25.1M
Q3 24
$-32.9M
$-46.2M
Q2 24
$-46.7M
$23.3M
Q1 24
$-43.9M
$-347.9M
Gross Margin
ANAB
ANAB
WW
WW
Q4 25
Q3 25
72.2%
Q2 25
Q1 25
71.2%
Q4 24
69.7%
Q3 24
67.1%
Q2 24
67.9%
Q1 24
66.7%
Operating Margin
ANAB
ANAB
WW
WW
Q4 25
61.8%
Q3 25
45.5%
5.8%
Q2 25
-117.5%
Q1 25
-99.2%
-10.8%
Q4 24
-22.4%
19.6%
Q3 24
-75.8%
-20.2%
Q2 24
-367.5%
17.8%
Q1 24
-587.8%
-130.4%
Net Margin
ANAB
ANAB
WW
WW
Q4 25
45.8%
Q3 25
19.8%
-30.5%
Q2 25
-173.5%
Q1 25
-141.6%
-38.9%
Q4 24
-50.5%
13.6%
Q3 24
-109.4%
-23.9%
Q2 24
-425.3%
11.5%
Q1 24
-612.0%
-168.4%
EPS (diluted)
ANAB
ANAB
WW
WW
Q4 25
$1.64
Q3 25
$0.52
$-5.63
Q2 25
$-1.34
Q1 25
$-1.28
$-0.91
Q4 24
$-0.63
$0.34
Q3 24
$-1.14
$-0.58
Q2 24
$-1.71
$0.29
Q1 24
$-1.64
$-4.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
WW
WW
Cash + ST InvestmentsLiquidity on hand
$238.2M
$170.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$37.2M
$323.0M
Total Assets
$364.4M
$968.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
WW
WW
Q4 25
$238.2M
Q3 25
$109.8M
$170.1M
Q2 25
$44.3M
Q1 25
$98.6M
$236.3M
Q4 24
$123.1M
$53.0M
Q3 24
$191.6M
$57.2M
Q2 24
$71.8M
$42.7M
Q1 24
$53.7M
$66.6M
Total Debt
ANAB
ANAB
WW
WW
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
ANAB
ANAB
WW
WW
Q4 25
$37.2M
Q3 25
$-29.4M
$323.0M
Q2 25
$-44.7M
Q1 25
$34.0M
$-1.2B
Q4 24
$70.9M
$-1.1B
Q3 24
$84.4M
$-1.1B
Q2 24
$9.9M
$-1.1B
Q1 24
$47.8M
$-1.1B
Total Assets
ANAB
ANAB
WW
WW
Q4 25
$364.4M
Q3 25
$353.1M
$968.8M
Q2 25
$335.3M
Q1 25
$422.1M
$696.9M
Q4 24
$483.8M
$550.3M
Q3 24
$493.4M
$562.4M
Q2 24
$427.4M
$614.3M
Q1 24
$405.8M
$654.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
WW
WW
Operating Cash FlowLast quarter
$98.0M
$8.4M
Free Cash FlowOCF − Capex
$98.0M
$8.4M
FCF MarginFCF / Revenue
90.5%
4.6%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$19.6M
$44.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
WW
WW
Q4 25
$98.0M
Q3 25
$-27.4M
$8.4M
Q2 25
$-40.2M
Q1 25
$-10.7M
$15.0M
Q4 24
$-66.7M
$4.6M
Q3 24
$-10.1M
$16.5M
Q2 24
$-21.3M
$-1.9M
Q1 24
$-37.3M
$-36.0M
Free Cash Flow
ANAB
ANAB
WW
WW
Q4 25
$98.0M
Q3 25
$-27.4M
$8.4M
Q2 25
$-40.3M
Q1 25
$-10.7M
$15.0M
Q4 24
$-66.9M
$4.5M
Q3 24
$-10.1M
$16.4M
Q2 24
$-21.4M
$-2.2M
Q1 24
$-37.3M
$-36.5M
FCF Margin
ANAB
ANAB
WW
WW
Q4 25
90.5%
Q3 25
-35.9%
4.6%
Q2 25
-180.9%
Q1 25
-38.7%
8.0%
Q4 24
-155.3%
2.4%
Q3 24
-33.7%
8.5%
Q2 24
-194.6%
-1.1%
Q1 24
-519.3%
-17.7%
Capex Intensity
ANAB
ANAB
WW
WW
Q4 25
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.2%
Q1 25
0.1%
0.0%
Q4 24
0.6%
0.1%
Q3 24
0.1%
0.1%
Q2 24
0.3%
0.1%
Q1 24
0.4%
0.2%
Cash Conversion
ANAB
ANAB
WW
WW
Q4 25
1.98×
Q3 25
-1.81×
Q2 25
Q1 25
Q4 24
0.18×
Q3 24
Q2 24
-0.08×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons